Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis ， Treatment， Genetic and Metabolic Liver Disease”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Large-scale testing (Phase 3)Study completedNCT00599326
What this trial is testing

Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
University of Texas Southwestern Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02949830
What this trial is testing

Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT01033747
What this trial is testing

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

Who this might be right for
Liver Iron Overload
Novartis Pharmaceuticals 70
Not applicableUnknownNCT05601557
What this trial is testing

Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver Disease

Who this might be right for
Diagnosis ， Treatment， Genetic and Metabolic Liver Disease
Sujun Zheng 480
Testing effectiveness (Phase 2)Study completedNCT03173521
What this trial is testing

Gene Therapy in Patients With Mucopolysaccharidosis Disease

Who this might be right for
Mucopolysaccharidosis Type VI
Fondazione Telethon 9
Testing effectiveness (Phase 2)Study completedNCT01573754
What this trial is testing

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
The University of Texas Medical Branch, Galveston 48
Testing effectiveness (Phase 2)Study completedNCT01307098
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency

Who this might be right for
Cholesterol Ester Storage Disease(CESD)Lysosomal Acid Lipase DeficiencyLAL-Deficiency
Alexion Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT02740153
What this trial is testing

PCORI Urea Cycle Disorder Study

Who this might be right for
Urea Cycle Disorders
Children's National Research Institute 187
Post-approval studies (Phase 4)Study completedNCT01552369
What this trial is testing

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 205
Large-scale testing (Phase 3)Study completedNCT00212355
What this trial is testing

Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Who this might be right for
Wilson's Disease
Nobelpharma 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02171104
What this trial is testing

MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

Who this might be right for
Mucopolysaccharidosis DisordersHurler SyndromeHunter Syndrome+26 more
Masonic Cancer Center, University of Minnesota 149
Not applicableLooking for participantsNCT06273644
What this trial is testing

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Who this might be right for
Porphyria, Acute Intermittent
Nordlandssykehuset HF 50
Large-scale testing (Phase 3)Looking for participantsNCT07465718
What this trial is testing

Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.

Who this might be right for
Wilson's Disease
Orphalan 38
Early research (Phase 1)Study completedNCT02943213
What this trial is testing

Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride

Who this might be right for
Anti-PsychoticManagement of Manifestations of Psychotic DisordersTreatment of Schizophrenia+6 more
Cycle Pharmaceuticals Ltd. 20
Not applicableStudy completedNCT01556113
What this trial is testing

Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver DiseaseSteatohepatitisHypertriglyceridemia+1 more
Yale University 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07641140
What this trial is testing

Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease

Who this might be right for
Wilson's Disease
Lingyi Biotech Co., Ltd. 18
Not applicableStudy completedNCT04171635
What this trial is testing

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

Who this might be right for
MRI Scans
Weill Medical College of Cornell University 55
Not applicableStudy completedNCT03299829
What this trial is testing

A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

Who this might be right for
Trientine Treatment for Wilson's Disease
Excelsior 48
Not applicableUnknownNCT02752529
What this trial is testing

The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter

Who this might be right for
Cirrhosis, Liver
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 415
Testing effectiveness (Phase 2)Study completedNCT01488097
What this trial is testing

Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency

Who this might be right for
Cholesterol Ester Storage Disease (CESD)Lysosomal Acid Lipase DeficiencyLAL-Deficiency
Alexion Pharmaceuticals, Inc. 8
Next Page